Biosimilars and Trademarks Issues
Pharmaceutical products are part of a heavily regulated market20/09/2018
{{article.published}}
Robert Valenti DLA Piper
Loading
Loading
20/09/2018 Robert Valenti, DLA Piper, Italy
{{article.published}}